<code id='BE4715D764'></code><style id='BE4715D764'></style>
    • <acronym id='BE4715D764'></acronym>
      <center id='BE4715D764'><center id='BE4715D764'><tfoot id='BE4715D764'></tfoot></center><abbr id='BE4715D764'><dir id='BE4715D764'><tfoot id='BE4715D764'></tfoot><noframes id='BE4715D764'>

    • <optgroup id='BE4715D764'><strike id='BE4715D764'><sup id='BE4715D764'></sup></strike><code id='BE4715D764'></code></optgroup>
        1. <b id='BE4715D764'><label id='BE4715D764'><select id='BE4715D764'><dt id='BE4715D764'><span id='BE4715D764'></span></dt></select></label></b><u id='BE4715D764'></u>
          <i id='BE4715D764'><strike id='BE4715D764'><tt id='BE4715D764'><pre id='BE4715D764'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:897
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          I learned firsthand about improving diversity in clinical trials
          I learned firsthand about improving diversity in clinical trials

          Asthebiopharmaceuticalindustryplacesincreasedemphasisonimprovingthediversityofparticipantsinclinical

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          A letter from the executive editor: STAT UnitedHealth investigation

          MikeReddyforSTATIwanttobringyourattentiontoavitallyimportant investigation STAThaspublishedtoday.For